Provided by Tiger Trade Technology Pte. Ltd.

Vertex Pharmaceuticals

452.63
-1.3700-0.30%
Volume:98.01K
Turnover:44.73M
Market Cap:114.84B
PE:29.55
High:463.78
Open:459.44
Low:451.85
Close:454.00
52wk High:513.98
52wk Low:362.50
Shares:253.72M
Float Shares:253.72M
Volume Ratio:0.56
T/O Rate:0.04%
Dividend:- -
Dividend Rate:- -
EPS(TTM):15.32
EPS(LYR):15.32
ROE:22.54%
ROA:12.16%
PB:6.15
PE(LYR):29.55

Loading ...

Apr 27, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Apr 12, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Apr 12, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Apr 04, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Mar 24, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Mar 17, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Mar 16, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Mar 13, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Mar 10, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Feb 13, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 09, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 07, 2023

Major Issues Report

8-K - Current report
Oct 28, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 27, 2022

Major Issues Report

8-K - Current report
Sep 26, 2022

Correspondence

CORRESP [Cover] - Correspondence
Aug 05, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 05, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Aug 04, 2022

Major Issues Report

8-K - Current report
Jul 11, 2022

Major Issues Report

8-K - Current report